2021-11-16-世界卫生组织-Cervical_cancer_Colombia_2021_country_profile_1页_65kb

Colombia Cervical Cancer Profile Summary

Morbidity and Mortality

• Crude cervical cancer incidence rate: 18.3 per 100,000 women (2020).
• Age-standardized cervical cancer incidence rate: 14.9 per 100,000 women (2020).
• Cervical cancer mortality data not fully specified, but total female deaths in 2019 were 108,000; a value of 2,300 deaths may be referenced but year and context uncertain.
• Mortality-to-incidence ratio: 0.53 (2020).
• Female population: 25,630,000 (estimated, 2019).
• Population-based cancer registry established: 2021.

Primary Prevention

• National HPV vaccination program introduced: 2012.
• Coverage: Approximately 57% of target population (9-14-year-old girls).
• By age 15, vaccination coverage: About 33–34%.
• Target cohort: Girls aged 9–17 years for first dose, final dose by age 15.
• Related risk factor data: Tobacco use prevalence among women aged 15+: 1.5% (2020 estimate).
• HPV immunization uptake: High among women, with 90% vaccinated by age 15; 3% reported cervical disease following vaccination.

Secondary Prevention Screening

• National cervical cancer screening program exists: 2021.
• Primary screening test: Cytology.
• Target age range: 25–69 years.
• Screening participation: About 8% of women screened in the last 5 years; ever screened: 74–81%.
• Clear protocols for early detection and referral systems: Exist, detailed for primary to tertiary healthcare transitions (2021 data).

Treatment and Supportive Care

• National cervical cancer management guidelines: Established 2021.
• Radiotherapy/brachytherapy units: Data varies, but medical staff exist, with specialized professionals like radiation oncologists (2019 count: 8 units per 10,000 patients).
• Cancer treatment availability: Radiotherapy, chemotherapy, etc., generally accessible, though some facilities limited (e.g., fewer radiotherapy units per patient).
• Palliative care supported: Available through public health system for non-communicable diseases.

WHO Cervical Cancer Elimination Strategy and Additional Indicators

• Alignment with WHO 2030 targets: Cervical cancer incidence and mortality reduction aimed.
• Related data: Registry confirmation (2021); comprehensive healthcare indicators including opioids (consumed in primary care), HIV incidence, etc., partially available or not.